NeoGenomics Inc (NEO)
Debt-to-equity ratio
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Total stockholders’ equity | US$ in thousands | 902,339 | 908,210 | 915,884 | 923,410 | 941,537 | 947,428 | 956,192 | 974,462 | 998,023 | 1,012,990 | 1,043,520 | 1,075,000 | 1,108,280 | 1,137,240 | 1,148,360 | 843,714 | 694,294 | 666,363 | 654,229 | 505,043 |
Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $902,339K
= 0.00
The debt-to-equity ratio of NeoGenomics Inc has remained constant at 0.00 throughout the periods from March 31, 2020, to December 31, 2024. This indicates that the company has not utilized any debt to finance its operations and growth, relying solely on equity financing. A debt-to-equity ratio of 0.00 signifies a very low risk of financial distress related to leverage, as there is no debt in the capital structure to amplify losses in case of downturns. This strategy can provide stability and financial flexibility but may also limit potential returns on investment. Overall, NeoGenomics Inc's consistent 0.00 debt-to-equity ratio suggests a conservative and financially secure capital structure.